A prospective controlled multicentre study of clarithromycin in pregnancy.
about
Clarithromycin in early pregnancy and the risk of miscarriage and malformation: a register based nationwide cohort studyPregnancy outcome following gestational exposure to azithromycinUse of antibiotics during pregnancy and risk of spontaneous abortion.Mini-review: history of organized teratology information services in North America.A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy.Antibiotic Treatment of Dogs and Cats during Pregnancy.Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems.Treatment of community-acquired lower respiratory tract infections during pregnancy.Pregnancy outcome after gestational exposure to erythromycin - a population-based register study from NorwayFetal safety of macrolidesMycobacterium avium complex infection in HIV/AIDS patients.Therapy of inflammatory bowel diseases in pregnancy and lactation.Safety of antimicrobial treatment during pregnancy: a current review of resistance, immunomodulation and teratogenicity.A Review of Antibiotic Use in Pregnancy.Antimalarial interaction of quinine and quinidine with clarithromycin.Postmarketing surveillance for human teratogenicity: a model approach.Exploration of human, rat, and rabbit embryonic cardiomyocytes suggests K-channel block as a common teratogenic mechanism.The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study.
P2860
Q21133773-41399800-3F68-486E-ACE7-1FA214413A3BQ33245155-ECA419BB-09C5-4BED-8271-DC9001D0035CQ33633484-E538DBE6-696F-4F52-A0B4-5C1DAE75DC3CQ33862579-BFA5295B-2DCA-4463-BD5E-CAA11C72D34CQ34185920-C345B741-8C4B-4180-9FE9-F0E839D585B6Q34495464-C8227D74-B014-4AE1-ADE7-473AFAA1750EQ35232225-4C179593-923C-4613-9DA4-1423905DA279Q35627688-A6372729-4EC2-4D30-ABEF-5D4B519BBE73Q36468164-048D871E-14A3-4E38-9FCF-251D46578FF2Q36969814-C2E25301-D569-4873-A521-2D766C543184Q37202852-1004E289-B921-46FB-A54F-77E3B1580EB1Q37615417-D05B8019-D2B8-47C6-8CBA-1A0C40AC82FBQ38246106-9A61D30C-8C13-461B-9EEB-315BB9C9D367Q38644820-837E5B43-9F9D-4D91-B0E3-9AE3182FF9CEQ45907681-035F97E7-97CF-47E4-B4BE-B3FA20BEE3FEQ46607993-751FD9DC-3340-4117-AE0F-443D152B9676Q50783983-E761DCF4-1164-4DEC-8FEC-9E8708F601ACQ52887870-17626B44-B93E-4A88-BED1-DC4FADA34A14
P2860
A prospective controlled multicentre study of clarithromycin in pregnancy.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
A prospective controlled multicentre study of clarithromycin in pregnancy.
@en
A prospective controlled multicentre study of clarithromycin in pregnancy.
@nl
type
label
A prospective controlled multicentre study of clarithromycin in pregnancy.
@en
A prospective controlled multicentre study of clarithromycin in pregnancy.
@nl
prefLabel
A prospective controlled multicentre study of clarithromycin in pregnancy.
@en
A prospective controlled multicentre study of clarithromycin in pregnancy.
@nl
P2093
P356
P1476
A prospective controlled multicentre study of clarithromycin in pregnancy.
@en
P2093
D'Alimonte D
Einarson A
Mastroiacova P
Phillips E
P304
P356
10.1055/S-2007-994053
P577
1998-01-01T00:00:00Z